Indian J Pharm Close
 

Table 4: Cetuximab in first-line therapy of recurrent/metastatic squamous cell carcinoma of the head and neck

Table 4: Cetuximab in first-line therapy of recurrent/metastatic squamous cell carcinoma of the head and neck